With this in mind, the Proteogenomics Research Institute for Systems Medicine (PRISM) investigated the proteomic map of tumor endothelium and discovered a potential target, Annexin A1 (37 kDa), which is overexpressed on tumor endothelial caveolae [3]. This evidence concerns the gene ANXA1 and neoplasm.